UK FMD (foot and mouth disease) animal restrictions lifted but tissue technology industry awaits:
This article was originally published in Clinica
Executive Summary
At the time of going to press, Clinica was awaiting confirmation from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) regarding possible changes to restrictions imposed on the trade of medical devices containing material sourced from biungulate animals, in light of the outbreaks of foot and mouth disease (FMD) in southern England earlier this month. Despite the early lifting of some restrictions on the movement and international trade of animals and products, an agency spokesperson could not confirm, on the eve of going to press, whether there had been any change to the situation, as set out in its August 14 notice (see Clinica No 1269, p 5).